DK527379A - Fremgangsmaade til fremstilling af 2-substituerede 19-nor-steroider - Google Patents
Fremgangsmaade til fremstilling af 2-substituerede 19-nor-steroiderInfo
- Publication number
- DK527379A DK527379A DK527379A DK527379A DK527379A DK 527379 A DK527379 A DK 527379A DK 527379 A DK527379 A DK 527379A DK 527379 A DK527379 A DK 527379A DK 527379 A DK527379 A DK 527379A
- Authority
- DK
- Denmark
- Prior art keywords
- steroids
- substituted
- preparing
- procedure
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
- C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
- C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
- C07J7/002—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/72—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 spiro-condensed with carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/006—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton spiro-condensed
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0007—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
- C07J5/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa not substituted in position 16
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
- C07J7/0065—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by an OH group free esterified or etherified
- C07J7/007—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by an OH group free esterified or etherified not substituted in position 17 alfa
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7835046A FR2444047A1 (fr) | 1978-12-13 | 1978-12-13 | Nouveaux derives 2,2-dimethyl 19-nor steroides, leur procede de preparation et leur application comme medicaments |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK527379A true DK527379A (da) | 1980-06-14 |
Family
ID=9216044
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK527379A DK527379A (da) | 1978-12-13 | 1979-12-12 | Fremgangsmaade til fremstilling af 2-substituerede 19-nor-steroider |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US4263290A (pt) |
| EP (2) | EP0044575B1 (pt) |
| JP (1) | JPS5585598A (pt) |
| AU (1) | AU527582B2 (pt) |
| CA (1) | CA1146531A (pt) |
| DK (1) | DK527379A (pt) |
| ES (1) | ES486791A0 (pt) |
| FI (1) | FI70027C (pt) |
| FR (1) | FR2444047A1 (pt) |
| HU (1) | HU180931B (pt) |
| IE (1) | IE49235B1 (pt) |
| PT (1) | PT70575A (pt) |
| SU (1) | SU1178325A3 (pt) |
| ZA (1) | ZA796194B (pt) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1994012523A1 (en) * | 1992-11-30 | 1994-06-09 | Mallinckrodt Medical, Inc. | Steroid-21-phosphate complex of technetium-99m |
| US20030083231A1 (en) * | 1998-11-24 | 2003-05-01 | Ahlem Clarence N. | Blood cell deficiency treatment method |
| FR2917975B1 (fr) * | 2007-06-26 | 2009-10-16 | Ceva Sante Animale Sa | Compositions et traitement de l'insuffisance cardiaque chez les animaux mammiferes non humains |
| US20090270356A1 (en) * | 2008-04-28 | 2009-10-29 | Ceva Sante Animale Sa | Compositions and treatments of heart failure in non-human mammal animals |
| CA2813433C (en) | 2010-10-27 | 2019-08-20 | Dignity Health | Trimegestone (tmg) for treatment of preterm birth |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1138460A (en) * | 1965-06-01 | 1969-01-01 | Merck & Co Inc | Steroid compounds |
| FR1476572A (fr) * | 1965-09-13 | 1967-04-14 | Gonènes synthétiques et leur procédé de préparation | |
| FR2322606A1 (fr) * | 1975-09-02 | 1977-04-01 | Roussel Uclaf | Nouveaux 2,2-dimethyl steroides, leur procede de preparation et leur application comme medicament |
| FR2364655A1 (fr) * | 1976-09-17 | 1978-04-14 | Roussel Uclaf | Nouveaux 2,2-dimethyl 19-nor steroides, leur procede de preparation et leur application comme medicament |
-
1978
- 1978-12-13 FR FR7835046A patent/FR2444047A1/fr active Granted
-
1979
- 1979-11-14 EP EP81200353A patent/EP0044575B1/fr not_active Expired
- 1979-11-14 EP EP79400873A patent/EP0012641B1/fr not_active Expired
- 1979-11-16 ZA ZA00796194A patent/ZA796194B/xx unknown
- 1979-11-23 HU HU79RO1045A patent/HU180931B/hu not_active IP Right Cessation
- 1979-11-30 US US06/098,766 patent/US4263290A/en not_active Expired - Lifetime
- 1979-12-10 SU SU792850118A patent/SU1178325A3/ru active
- 1979-12-10 FI FI793847A patent/FI70027C/fi not_active IP Right Cessation
- 1979-12-11 PT PT70575A patent/PT70575A/pt unknown
- 1979-12-12 AU AU53762/79A patent/AU527582B2/en not_active Ceased
- 1979-12-12 ES ES486791A patent/ES486791A0/es active Granted
- 1979-12-12 CA CA000341751A patent/CA1146531A/fr not_active Expired
- 1979-12-12 DK DK527379A patent/DK527379A/da not_active Application Discontinuation
- 1979-12-13 JP JP16090879A patent/JPS5585598A/ja active Granted
- 1979-12-13 IE IE2420/79A patent/IE49235B1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0012641A3 (en) | 1980-09-17 |
| AU5376279A (en) | 1980-07-10 |
| FI793847A (fi) | 1980-06-14 |
| EP0012641A2 (fr) | 1980-06-25 |
| EP0044575B1 (fr) | 1984-03-21 |
| ZA796194B (en) | 1980-11-26 |
| JPS6337796B2 (pt) | 1988-07-27 |
| FI70027B (fi) | 1986-01-31 |
| PT70575A (fr) | 1980-01-01 |
| FR2444047A1 (fr) | 1980-07-11 |
| US4263290A (en) | 1981-04-21 |
| FR2444047B1 (pt) | 1982-05-28 |
| AU527582B2 (en) | 1983-03-10 |
| CA1146531A (fr) | 1983-05-17 |
| JPS5585598A (en) | 1980-06-27 |
| SU1178325A3 (ru) | 1985-09-07 |
| EP0044575A1 (fr) | 1982-01-27 |
| IE49235B1 (en) | 1985-09-04 |
| EP0012641B1 (fr) | 1982-05-12 |
| HU180931B (en) | 1983-05-30 |
| ES8102149A1 (es) | 1980-12-16 |
| FI70027C (fi) | 1986-09-12 |
| ES486791A0 (es) | 1980-12-16 |
| IE792420L (en) | 1980-06-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK161333C (da) | Analogifremgangsmaade til fremstilling af 11beta-substituerede 4,9-dien-steroider | |
| DK149023C (da) | Analogifremgangsmaade til fremstilling af tiazolidinderivater | |
| DK363179A (da) | Fremgangsmaade til fremstilling af tetrazolylalkoxycarbostyrilderivater | |
| DK457779A (da) | Fremgangsmaade til fremstilling af 4-hydroxy-2-pyronderivater | |
| DK207279A (da) | Fremgangsmaade til fremstilling af e-vitaminpulver | |
| DK364579A (da) | Fremgangsmaade til fremstilling af n2-arylsulfonyl-l-arginiamider | |
| DK7579A (da) | Fremgangsmaade til fremstilling af (%n-diethylmeta-toluamid | |
| DK19579A (da) | Fremgangsmaade til fremstilling af spirothienohydantoinderivater | |
| DK488379A (da) | Fremgangsmaade til fremstilling af polyetherderivater | |
| DK161151C (da) | Analogifremgangsmaade til fremstilling af 10-alkynylsteroider | |
| DK46777A (da) | Fremgangsmade til fremstilling af meta-aryloxybenzaldehyder | |
| DK145698C (da) | Analogifremgangsmaade til fremstilling af 2-alkoxyadeninderivater | |
| DK147145C (da) | Analogifremgangsmaade til fremstilling af chlorambucilderivater | |
| DK165687C (da) | Fremgangsmaade til fremstilling af 2-chlorsulfinylazetidinoner | |
| DK150479C (da) | Fremgangsmaade til fremstilling af 2-chlor-5-trifluormethylpyridin | |
| DK161198C (da) | Analogifremgangsmaade til fremstilling af substituerede omega-aroylpropionyl-l-proliner | |
| DK330279A (da) | Fremgangsmaade til fremstilling af soem | |
| DK527379A (da) | Fremgangsmaade til fremstilling af 2-substituerede 19-nor-steroider | |
| DK188181A (da) | Fremgangsmaade til fremstilling af halogenerede steroider | |
| DK425478A (da) | Fremgangsmaade til fremstilling af injicerbare lipsomer | |
| DK196579A (da) | Fremgangsmaade til fremstilling af substituerede dibenzylethere | |
| DK140728B (da) | Fremgangsmåde til fremstilling af pregnanderivater. | |
| DK92192D0 (da) | Fremgangsmaade til fremstilling af a-homo-androstaner | |
| DK127179A (da) | Fremgangsmaade til fremstilling af monokaryoner | |
| DK158790C (da) | Fremgangsmaade til fremstilling af 24-oxo-steroidforbindelser |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AHS | Application shelved for other reasons than non-payment |